Ronnie Fass, MD
Gastroenterology · Cleveland, OHNPI 1780696997
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 25.2% of the total. Reporting peaked in 2023 at $39,344 and has fallen 77.0% since, to $9,052 in 2025. Among gastroenterology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $1157.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$31K
- Phathom Pharmaceuticals, Inc.$28K
- Intra-sana Laboratories$14K
- Medical Device Business Services, Inc.$11K
- Evoke Pharma, Inc.$9K
- Mylan Inc.$5K
- plus $24K from 12 others
Across 18 payments — averaging $7893.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$83K
- Medtronic$41K
- Ironwood Pharmaceuticals, Inc$16K
- AbbVie$2K
- Covidien LP$1K
What the payments were for
- Consulting fees$56,46846%
- Speaking & faculty fees$58,00347%
- Travel & lodging$5,8055%
- Food & beverage$2,4212%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $30,871 |
| Phathom Pharmaceuticals, Inc. | 52 | $27,833 |
| Intra-sana Laboratories | 9 | $14,350 |
| Medical Device Business Services, Inc. | 4 | $10,920 |
| Evoke Pharma, Inc. | 12 | $9,122 |
| Mylan Inc. | 1 | $5,330 |
| Amgen | 3 | $5,151 |
| GI Supply, Inc. | 1 | $5,063 |
| AbbVie | 1 | $2,750 |
| Braintree Laboratories, Inc. | 1 | $2,750 |
| Laborie Medical Technologies Corp. | 1 | $2,700 |
| Eisai CO., LTD. | 1 | $1,890 |
| Takeda | 1 | $1,569 |
| Sanofi | 2 | $826 |
| Covidien LP | 1 | $800 |
| Johnson & Johnson | 1 | $600 |
| Cook Medical LLC | 2 | $111 |
| Ironwood Pharmaceuticals, Inc | 1 | $60 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOQUEZNA$24,677
- Reltone 200 Mg$14,000
- GLYCATE$14,000
- Reltone 400 Mg$14,000
- Dexilant$11,000
- GIMOTI$8,831
- VOQUEZNA TRIPLE PAK$7,750
- VOQUEZNA DUAL PAK$7,750
- BOTOX$2,750
- Amitiza$2,476
- Entyvio$2,476
- LINX Reflux Management System$2,080
- Aciphex$1,890
- DUPIXENT$798
How this compares
$122,696 in reported general payments places this provider in the 95th percentile of 657 gastroenterology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexlansoprazole DrDexlansoprazole | 23 | $4,682 |
| Omeprazole | 34 | $728 |
| Esomeprazole Magnesium | 12 | $471 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Cleveland
- Pierre GholamCleveland$1.6M
- Florian RiederCleveland$396K
- Stanley CohenCleveland$338K
- Taha QaziCleveland$307K
- Vu NguyenCleveland$145K
- Benjamin CohenCleveland$144K
- Imad AsaadCleveland$141K
- Amit BhattCleveland$118K
- Anjana PillaiCleveland$115K
- Amandeep SinghCleveland$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.